GSK plc 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 4:46 pm Purchase | 2021-12-31 | 13G | Vir Biotechnology, Inc. VIR | GSK plc | 8,550,954 6.500% | 1,924,927 (+29.05%) | Filing |